Last Price
0.458
Today's Change
+0.149 (48.22%)
Day's Change
0.432 - 0.96
Trading Volume
567,523,762
Profile
ERNA
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Sanjeev Luther Mr. Sanjeev Luther
Full Time Employees: 8 8
IPO Date: 1991-08-29 1991-08-29
CIK: 0000748592 0000748592
ISIN: US1140822099 US1140822099
CUSIP: 114082209 114082209
Beta: 7.77 7.77
Last Dividend: 0.00 0.00
Dcf Diff: -0.19 -0.19
Dcf: 2.40 2.40
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
Los Angeles Struggles to Battle Fires as Pentagon Offers Aid
3
CEO Morning Brief
4
CEO Morning Brief
Wall Street May Lose Up to 200,000 Jobs as AI Takes Over Their Roles
5
CEO Morning Brief
US Companies Announced Fewest Hires in 2024 in Nearly a Decade
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
